Table 2. Patterns of prior antiviral treatment and genotypic resistance analysis in NA-exp patients.
Mo, month; LAM, lamivudine; LAM-R, lamivudine resistance; LdT, telbivudine; ADV, adefovir; ETV, entecavir.
Mo, month; LAM, lamivudine; LAM-R, lamivudine resistance; LdT, telbivudine; ADV, adefovir; ETV, entecavir.